AIMC Topic: Tumor Suppressor Proteins

Clear Filters Showing 11 to 20 of 35 articles

MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning models.

Medical image analysis
The number of studies on deep learning for medical diagnosis is expanding, and these systems are often claimed to outperform clinicians. However, only a few systems have shown medical efficacy. From this perspective, we examine a wide range of deep l...

A Comparison of Three Different Deep Learning-Based Models to Predict the MGMT Promoter Methylation Status in Glioblastoma Using Brain MRI.

Journal of digital imaging
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. The standard treatment for GBM consists of surgical resection followed by concurrent chemoradiotherapy and adjuvant temozolomide. O-6-methylguanine-DNA methyltransferase (...

MRI-Based Deep-Learning Method for Determining Glioma Promoter Methylation Status.

AJNR. American journal of neuroradiology
BACKGROUND AND PURPOSE: () promoter methylation confers an improved prognosis and treatment response in gliomas. We developed a deep learning network for determining promoter methylation status using T2 weighted Images (T2WI) only.

Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis.

BioMed research international
Methylation of the O-methylguanine methyltransferase (MGMT) gene promoter is correlated with the effectiveness of the current standard of care in glioblastoma patients. In this study, a deep learning pipeline is designed for automatic prediction of M...

Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections.

Translational vision science & technology
BACKGROUND: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Monosomy 3 and mutation are strong prognostic factors predicting metastatic risk in UM. Nuclear BAP1 (nBAP1) expression is a close immunohistochemical surro...